AI already tells your medicine’s story. Know it. Act on it.
ceel.ai shows Medical Affairs, Brand and Market Access teams what AI tells physicians and patients about their medicine, where it departs from the label and evidence, and what to do next.
“Diarrhoea on Talvirex is a reason to stop treatment. The SmPC says it can usually be managed.”
AI is already part of the conversation about treatment. Your scientific message needs to survive the AI retelling.
- 61%of physicians in DACH use AI tools several times a week or dailySource: FOMF survey, 2026
- 52%of US doctors use generative AI daily at workSource: Wolters Kluwer / Ipsos, 2026
- 39%of US physicians use AI to summarise medical research and standards of careSource: AMA, 2026
- 14%of recent US users of AI for health say its advice led them to skip a doctor’s visitSource: West Health-Gallup, April 2026
What you can do
From narrative to action.
Make sure what AI says is safe.
Catch answers that depart from your label and route them to pharmacovigilance and medical review. Governance Shield →
Equip your field force.
Brief Medical and the field on what physicians hear from AI, step by step. Competitive Benchmarking →
Ground answers in trusted evidence.
Know which evidence carries each step, and close the gaps where guidelines and peer-reviewed data are missing. Publication Planning →
Shape the narrative.
Find where your story diverges, and answer it with clear, evidence-based communication. Competitive Benchmarking →
Make your launch land.
See how new data and congress results come through from day one, before the story sets. Congress Echo →
Competitive Benchmarking
Where do you stand against your competitors?
Situation
Physicians compare treatments with AI before they talk to your field force. You don’t know which therapy comes out ahead, or why.
With ceel.ai
ceel.ai scores every step of the treatment journey on nine dimensions, model by model and against each competitor.
Result
You know where you lead, where you trail, and which step and competitor to address first.
Gemini 3.6 Flash favours Talvirex on safety in 88% of comparisons. GPT-6.1 Sol calls it a tie.
Congress Echo
See whether your congress data reaches the conversation.
Situation
You present new data at a congress. Weeks later, nobody knows whether AI answers mention it.
With ceel.ai
ceel.ai runs your questions on every model, twice a day, from a week before the congress to a week after.
Result
You see when your new data comes through, where it doesn’t, and where to follow up.
of citations lead to the abstract only. The full paper is behind a paywall.
Publication Planning
Know what to publish, and where.
Situation
Your publication plan is set for the next two years. It’s unclear which papers AI actually draws on, and where the gaps are.
With ceel.ai
ceel.ai shows which publications carry the narrative at each step, the journals behind them and the authors AI cites most.
Result
You prioritise topics, journals and KOLs for your next publications, based on evidence.
Governance Shield
Know what AI says about safety, before it scales.
Situation
Patients and physicians ask AI about side effects every day. Nobody checks those answers against your label.
With ceel.ai
ceel.ai checks safety statements and switching advice in AI answers against your SmPC.
Result
Flagged statements go to pharmacovigilance and medical review, with the evidence attached.
- Not supported by SmPC“Photosensitivity is a common side effect of Talvirex.”9% of answers · 2 models
- Wrong citation“No liver monitoring is needed on Talvirex.”Cited to the phase 3 trial, which reports elevated liver enzymes
- Stopping advice12 answers advise stopping Talvirex without a referral.Patient persona · side effects
FAQ
Questions pharma teams ask.
What do ChatGPT and other AI models tell physicians and patients about our drug?
ceel.ai asks leading AI models the questions your audiences ask, as simulated physicians, patients and caregivers in their country and language. You see which narratives the answers tell about your medicine, which evidence they cite and where they diverge from your key messages.
How does AI compare our medicine with competitors?
Treatment Journey scores each step from first symptoms to clinical evidence and compares your medicine with each competitor on nine dimensions, such as efficacy, safety and access, model by model.
How can we check whether AI safety statements match our SmPC?
Governance Shield compares safety statements in AI answers with your SmPC and flags off-label mentions, blind spots and advice to stop or switch treatment. Flags are candidates for pharmacovigilance and medical review, not confirmed errors.
Does our congress data show up in AI answers?
Congress Echo asks your questions on every model twice a day, from a week before the congress to a week after. You see whether and when new data appears in the answers, and which sources carry it.
Which publications, journals and authors shape AI answers in our indication?
Publication Planning resolves every cited link to its publication, with journal, authors and access level, for each step of the treatment journey. A citation shows what a model referenced, not what shaped its answer.
Is ceel.ai an SEO or GEO tool?
No, ceel.ai is not a GEO tool. GEO tools track isolated prompts that someone has to write and maintain. We analyse whole conversations, because that is how people use AI: a physician or patient asks a series of questions, and each answer builds on the last. ceel.ai maps these conversations along the treatment journey, from diagnosis and treatment choice to side effects and clinical evidence, for physicians, patients and caregivers in their country and language. Nobody on your team has to write prompts. Every answer is checked against your label and evidence, and the findings become concrete actions for Medical Affairs, Brand and Market Access.
| Core capabilities | ceel.ai | Typical GEO |
|---|---|---|
| How visible are my brands and medicines in AI answers? | ||
| What is the AI reach¹ of each medicine across relevant HCP and patient questions? | ||
| Which narrative does AI tell about each medicine? | ||
| Do safety statements in AI answers match my SmPC? | ||
| Which scientific publications does AI cite for each narrative, resolved to the actual paper? | ||
| Does my new congress data reach AI answers, and how fast? |
¹ AI reach: how often a medicine appears across relevant AI questions and answer touchpoints.
Does ceel.ai change what AI models say?
No, and we don’t try to. ceel.ai shows what AI models say about your medicine and where it departs from your label or evidence. Then we give your teams concrete, evidence-based actions for safer, on-label narratives, matched to your indication and the medical needs of your audiences. Every action goes through your medical, legal and regulatory review.
How do we start?
Most teams start with a Proof of Value for one indication, two personas and two countries, and move to the full platform once the value is clear.
Security
Built for regulated teams.
Medical, regulatory and compliance teams need to know how their data is handled. Our controls, policies and audit status are published in the Trust Center.
GDPR
EU compliant
SOC 2 Type II
Audit in progress
See where your narrative stands, and what to do next.
A 30-minute conversation about your indication, your competitors and your audiences.